James A Blumenthal1, Patrick J Smith2, Stephanie Mabe2, Alan Hinderliter2, Pao-Hwa Lin2, Lawrence Liao2, Kathleen A Welsh-Bohmer2, Jeffrey N Browndyke2, William E Kraus2, P Murali Doraiswamy2, James R Burke2, Andrew Sherwood2. 1. From the Departments of Psychiatry and Behavioral Sciences (J.A.B., P.J.S., S.M., K.A.W.-B., J.N.B., P.M.D., A.S.), Medicine (P.-H.L., L.L., W.E.K., P.M.D.), and Neurology (K.A.W.-B., J.R.B.), Duke University Medical Center, Durham; and Department of Medicine (A.H.), University of North Carolina at Chapel Hill. James.Blumenthal@duke.edu. 2. From the Departments of Psychiatry and Behavioral Sciences (J.A.B., P.J.S., S.M., K.A.W.-B., J.N.B., P.M.D., A.S.), Medicine (P.-H.L., L.L., W.E.K., P.M.D.), and Neurology (K.A.W.-B., J.R.B.), Duke University Medical Center, Durham; and Department of Medicine (A.H.), University of North Carolina at Chapel Hill.
Abstract
OBJECTIVE: To determine the independent and additive effects of aerobic exercise (AE) and the Dietary Approaches to Stop Hypertension (DASH) diet on executive functioning in adults with cognitive impairments with no dementia (CIND) and risk factors for cardiovascular disease (CVD). METHODS: A 2-by-2 factorial (exercise/no exercise and DASH diet/no DASH diet) randomized clinical trial was conducted in 160 sedentary men and women (age >55 years) with CIND and CVD risk factors. Participants were randomly assigned to 6 months of AE, DASH diet nutritional counseling, a combination of both AE and DASH, or health education (HE). The primary endpoint was a prespecified composite measure of executive function; secondary outcomes included measures of language/verbal fluency, memory, and ratings on the modified Clinical Dementia Rating Scale. RESULTS: Participants who engaged in AE (d = 0.32, p = 0.046) but not those who consumed the DASH diet (d = 0.30, p = 0.059) demonstrated significant improvements in the executive function domain. The largest improvements were observed for participants randomized to the combined AE and DASH diet group (d = 0.40, p = 0.012) compared to those receiving HE. Greater aerobic fitness (b = 2.3, p = 0.049), reduced CVD risk (b = 2.6, p = 0.042), and reduced sodium intake (b = 0.18, p = 0.024) were associated with improvements in executive function. There were no significant improvements in the memory or language/verbal fluency domains. CONCLUSIONS: These preliminary findings show that AE promotes improved executive functioning in adults at risk for cognitive decline. CLINICALTRIALSGOV IDENTIFIER: NCT01573546. CLASSIFICATION OF EVIDENCE: This study provides Class I evidence that for adults with CIND, AE but not the DASH diet significantly improves executive functioning.
OBJECTIVE: To determine the independent and additive effects of aerobic exercise (AE) and the Dietary Approaches to Stop Hypertension (DASH) diet on executive functioning in adults with cognitive impairments with no dementia (CIND) and risk factors for cardiovascular disease (CVD). METHODS: A 2-by-2 factorial (exercise/no exercise and DASH diet/no DASH diet) randomized clinical trial was conducted in 160 sedentary men and women (age >55 years) with CIND and CVD risk factors. Participants were randomly assigned to 6 months of AE, DASH diet nutritional counseling, a combination of both AE and DASH, or health education (HE). The primary endpoint was a prespecified composite measure of executive function; secondary outcomes included measures of language/verbal fluency, memory, and ratings on the modified Clinical Dementia Rating Scale. RESULTS: Participants who engaged in AE (d = 0.32, p = 0.046) but not those who consumed the DASH diet (d = 0.30, p = 0.059) demonstrated significant improvements in the executive function domain. The largest improvements were observed for participants randomized to the combined AE and DASH diet group (d = 0.40, p = 0.012) compared to those receiving HE. Greater aerobic fitness (b = 2.3, p = 0.049), reduced CVD risk (b = 2.6, p = 0.042), and reduced sodium intake (b = 0.18, p = 0.024) were associated with improvements in executive function. There were no significant improvements in the memory or language/verbal fluency domains. CONCLUSIONS: These preliminary findings show that AE promotes improved executive functioning in adults at risk for cognitive decline. CLINICALTRIALSGOV IDENTIFIER: NCT01573546. CLASSIFICATION OF EVIDENCE: This study provides Class I evidence that for adults with CIND, AE but not the DASH diet significantly improves executive functioning.
Authors: A F Kramer; S Hahn; N J Cohen; M T Banich; E McAuley; C R Harrison; J Chason; E Vakil; L Bardell; R A Boileau; A Colcombe Journal: Nature Date: 1999-07-29 Impact factor: 49.962
Authors: Heidi Wengreen; Ronald G Munger; Adele Cutler; Anna Quach; Austin Bowles; Christopher Corcoran; Joann T Tschanz; Maria C Norton; Kathleen A Welsh-Bohmer Journal: Am J Clin Nutr Date: 2013-09-18 Impact factor: 7.045
Authors: Elena H Martínez-Lapiscina; Pedro Clavero; Estefania Toledo; Ramon Estruch; Jordi Salas-Salvadó; Beatriz San Julián; Ana Sanchez-Tainta; Emilio Ros; Cinta Valls-Pedret; Miguel Á Martinez-Gonzalez Journal: J Neurol Neurosurg Psychiatry Date: 2013-05-13 Impact factor: 10.154
Authors: Nikolaos Scarmeas; Jose A Luchsinger; Nicole Schupf; Adam M Brickman; Stephanie Cosentino; Ming X Tang; Yaakov Stern Journal: JAMA Date: 2009-08-12 Impact factor: 56.272
Authors: M Siervo; R Arnold; J C K Wells; A Tagliabue; A Colantuoni; E Albanese; C Brayne; B C M Stephan Journal: Obes Rev Date: 2011-07-18 Impact factor: 9.213
Authors: Emilie T Reas; Gail A Laughlin; Jaclyn Bergstrom; Donna Kritz-Silverstein; Linda K McEvoy Journal: J Alzheimers Dis Date: 2019 Impact factor: 4.472
Authors: Taylor J Krivanek; Seth A Gale; Brittany M McFeeley; Casey M Nicastri; Kirk R Daffner Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472
Authors: Richard S Isaacson; Hollie Hristov; Nabeel Saif; Katherine Hackett; Suzanne Hendrix; Juan Melendez; Joseph Safdieh; Matthew Fink; Madhav Thambisetty; George Sadek; Sonia Bellara; Paige Lee; Cara Berkowitz; Aneela Rahman; Josefina Meléndez-Cabrero; Emily Caesar; Randy Cohen; Pei-Lin Lu; Samuel P Dickson; Mu Ji Hwang; Olivia Scheyer; Monica Mureb; Matthew W Schelke; Kellyann Niotis; Christine E Greer; Peter Attia; Lisa Mosconi; Robert Krikorian Journal: Alzheimers Dement Date: 2019-10-31 Impact factor: 21.566
Authors: Patrick J Smith; Andrew Sherwood; Alan L Hinderliter; Stephanie Mabe; Lana L Watkins; Linda Craighead; Krista Ingle; Crystal Tyson; Forgive Avorgbedor; Pao-Hwa Lin; William E Kraus; Lawrence Liao; James A Blumenthal Journal: J Hypertens Date: 2022-06-10 Impact factor: 4.776
Authors: James A Blumenthal; Patrick J Smith; Stephanie Mabe; Alan Hinderliter; Kathleen Welsh-Bohmer; Jeffrey N Browndyke; P Murali Doraiswamy; Pao-Hwa Lin; William E Kraus; James R Burke; Andrew Sherwood Journal: J Am Geriatr Soc Date: 2019-11-22 Impact factor: 5.562
Authors: Giuseppe Faraco; Karin Hochrainer; Steven G Segarra; Samantha Schaeffer; Monica M Santisteban; Ajay Menon; Hong Jiang; David M Holtzman; Josef Anrather; Costantino Iadecola Journal: Nature Date: 2019-10-23 Impact factor: 49.962
Authors: Carolyn S Kaufman; Robyn A Honea; Joseph Pleen; Rebecca J Lepping; Amber Watts; Jill K Morris; Sandra A Billinger; Jeffrey M Burns; Eric D Vidoni Journal: J Cereb Blood Flow Metab Date: 2021-01-28 Impact factor: 6.200
Authors: Anne L Shandera-Ochsner; Melanie J Chandler; Dona E Locke; Colleen T Ball; Julia E Crook; Vaishali S Phatak; Glenn E Smith Journal: J Int Neuropsychol Soc Date: 2021-07-26 Impact factor: 2.892